Skip to main content

Infographic - Creating Impact Through Thematic Investing

Posted on February 6, 2020

Martin Vezér
Martin Vezér
ESG Research Associate Director, Thematic Research

In this year’s edition of our 10 for series, we put an environmental, social and governance (ESG) lens on 10 investment themes that may offer investors an opportunity to create a positive social and environmental impact through the equity market. The trends we identify are driven by corporate initiatives to scale new technologies, improve social conditions, conserve ecosystems and mitigate climate change.

For each of the 10 themes, we analyze a basket of companies and identify a firm that we regard as relatively well positioned from an ESG risk perspective. As outlined in the infographic below, we also assess each theme against the Sustainable Development Goals (SDGs).

Over the next few weeks, several of the contributors to 10 for 2020: Creating Impact Through Thematic Investing will publish blog posts elaborating on topics covered in the report. We hope that the report and this blog series will help investors develop new ways to promote the SDGs while gaining in the equities market.

10 for 2020 inforgraphic

Recent Content

Tire Supply Chains Face Rising Deforestation Risks as Traceability Requirements Tighten

Exploring how deforestation regulations and traceability requirements are reshaping natural rubber sourcing and ESG risks across tire supply chains.

Frameworks in Focus: Comparing NZIF 2.0 and SBTi Net Zero Standard for Financial Institutions

This article provides a comparison of NZIF 2.0 and the SBTi Net Zero Standard for Financial Institutions, and explores what they reveal about portfolio alignment, and climate transition strategies for asset owners and asset managers.

Heat, Policy and Portfolios: What This Summer's Climate Moment Revealed About Investor Priorities

Exploring how climate transition, nature investing and physical risk are reshaping investor priorities and portfolio strategies in a changing market.

US, Europe Biopharma Partnerships With Chinese Firms: Evaluating ESG Risks

Examining the ESG and geopolitical risks shaping US and European biopharma partnerships with Chinese firms.